The arrival of cell-based therapies is a revolution in medicine. However, its safe clinical
application in a rational manner depends on reliable, clinically applicable methods for …

To the extent that pharmacokinetics influence the effectiveness of nonliving therapeutics, so
too do cellular kinetics influence the efficacy of Chimeric Antigen Receptor (CAR)-T cell …

Cell therapy with polyclonal regulatory T cells (Tregs) has been translated into the clinic and
is currently being tested in transplant recipients and patients suffering from autoimmune …

Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and
molecular imaging (MI), including positron emission tomography (PET), single-photon …

Chimeric antigen receptor T cell therapy (CAR-T) has been rolled out as a new treatment for
hematological malignancies. For solid tumor treatment, CAR-T has been disappointing so …

The positron emission tomography (PET) molecular imaging technique has gained its
universal value as a remarkable tool for medical diagnosis and biomedical research …

Cloning of the sodium iodide symporter (NIS) 25 years ago has opened an exciting chapter
in molecular thyroidology with the characterization of NIS as one of the most powerful …

Near-infrared dyes have attracted widespread attention due to their intense absorption and
emission in the near-infrared region. As an important class of heteroatom-containing …

Diagnostic molecular images, obtained by positron emission tomography (PET), have
successfully functioned as sensitive tools for detecting and monitoring the treatment of …

Regulatory T cells (Tregs) are a promising candidate cell therapy to treat autoimmune
diseases and aid the longevity of transplanted solid organs. Despite increasing numbers of …